Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 6kWORD 20k
13 May 2016
E-001709/2016(ASW)
Answer given by Ms Jourová on behalf of the Commission
Question reference: E-001709/2016

The Commission would like to refer the Honourable Members to its reply to Question E-013116/2015(1) regarding health related information to consumers on tampons. The toxic shock syndrome (TSS) is a rare but serious medical condition caused by a bacterial infection which has been associated (among other causes) with the use of tampons. The study which is referred to does not establish any proven correlation between the use of certain ingredients in tampons and the occurrence of the TSS. The Commission has taken note of the communication of the French authorities of 4 March 2016 that recent studies have not revealed any risk for consumers and confirms that it is currently not considering specific regulatory actions concerning tampons.

Restrictions on the manufacture, the placing on the market or the use of chemical substances is harmonised by the REACH Regulation which, for example, bans the use of certain hazardous chemicals (Dioctyltin (DOT) compounds) in female hygiene products(2). Further restrictions under REACH can be envisaged if the presence of hazardous chemicals in tampons is proven to pose a risk to consumers.

(1)http://www.europarl.europa.eu/sides/getAllAnswers.do?reference=E-2015-013116&language=EN
(2)Annex XVII, entry 20, of Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18.12.2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), OJ L 396, 30.12.2006, p. 1.

Legal notice